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ARTICLE
Genome-wide analysis of epistasis in body mass
index using multiple human populations
Wen-Hua Wei*,1, Gib Hemani2, Attila Gyenesei3, Veronique Vitart1, Pau Navarro1, Caroline Hayward1,
Claudia P Cabrera1, Jennifer E Huffman1, Sara A Knott4, Andrew A Hicks5, Igor Rudan6,7,
Peter P Pramstaller5,8,9, Sarah H Wild6, James F Wilson6, Harry Campbell6, Nicholas D Hastie1,
Alan F Wright1 and Chris S Haley1,2
We surveyed gene–gene interactions (epistasis) in human body mass index (BMI) in four European populations (no1200) via
exhaustive pair-wise genome scans where interactions were computed as F ratios by testing a linear regression model fitting
two single-nucleotide polymorphisms (SNPs) with interactions against the one without. Before the association tests, BMI was
corrected for sex and age, normalised and adjusted for relatedness. Neither single SNPs nor SNP interactions were genome-wide
significant in either cohort based on the consensus threshold (P¼5.0E08) and a Bonferroni corrected threshold (P¼1.1E12),
respectively. Next we compared sub genome-wide significant SNP interactions (Po5.0E08) across cohorts to identify common
epistatic signals, where SNPs were annotated to genes to test for gene ontology (GO) enrichment. Among the epistatic genes
contributing to the commonly enriched GO terms, 19 were shared across study cohorts of which 15 are previously published
genome-wide association loci, including CDH13 (cadherin 13) associated with height and SORCS2 (sortilin-related VPS10
domain containing receptor 2) associated with circulating insulin-like growth factor 1 and binding protein 3. Interactions
between the 19 shared epistatic genes and those involving BMI candidate loci (Po5.0E08) were tested across cohorts and
found eight replicated at the SNP level (Po0.05) in at least one cohort, which were further tested and showed limited
replication in a separate European population (n45000). We conclude that genome-wide analysis of epistasis in multiple
populations is an effective approach to provide new insights into the genetic regulation of BMI but requires additional efforts
to confirm the findings.
European Journal of Human Genetics (2012) 20, 857–862; doi:10.1038/ejhg.2012.17; published online 15 February 2012
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INTRODUCTION
Body mass index (BMI) is the most commonly used anthropometric
method to define human obesity. BMI is a complex trait affected by
many environmental (eg, diet, age, physical activity) and genetic
factors, with heritability estimates that vary from 40–80% in twin
studies, 20–50% in family studies and 20–60% in adoption studies.1
Recent genome-wide association (GWA) studies have successfully
identified numerous single-nucleotide polymorphisms (SNPs) that
are robustly associated with obesity related traits, including BMI.2–4
They shed light on the biological basis of obesity and suggest a role for
neuronal influences on the regulation of appetite and/or energy
balance. However, the identified genetic variants jointly explained
only a small proportion of the trait variation and thus had limited
predictive value for obesity risk.5 For example, in a recent meta-
analysis (249 796 individuals) 32 identified and replicated SNPs
together explained only 1.45% of the inter-individual variation
in BMI where the strongest SNP accounted for just 0.34% of the
variance.3 The 32 BMI SNPs map to 32 different genes that are
referred to as BMI loci hereafter.
Gene–gene interactions (epistasis) are thought to be potential
sources of the unexplained genetic variation,6–8 but they remain
largely unexplored in the GWA studies conducted for BMI so far.
A major hurdle for analysing epistasis in GWA studies was the lack of
fast methods to enumerate billions of interaction tests in a full pair-
wise genome scan to map different types of epistasis (eg, with or
without main effects) while keeping false-positive rates under con-
trol.9,10 Another hurdle for studying epistasis is the relatively small
sample size in many existing GWA cohorts that may limit the power of
detection and replication of epistasis signals unless the epistatic effects
to be detected are large.11,12 It was showed in simulation that more
than 4000 case–control pairs were needed to achieve 80% power of
detection of epistasis with an odds ratio of 3.0 in complex diseases.13
For quantitative traits, sample sizes need to be substantially (eg, 45%)
larger than case–control phenotypes to achieve a similar power.14
With the advances in computing technologies, the major hurdle is
gradually easing and full pair-wise genome scans are beginning to
be applied to GWA populations individually.15,16 Meta-analysis of
epistasis as applied in GWA studies3 could be a good way to overcome
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the sample size hurdle but requires new methods to accommodate
imputed SNP genotype data. Various approaches in search space
reduction (ie, less stringent significance thresholds as result of the
much reduced number of tests) can be applied to improve the power
of detection of epistasis in individual GWA populations.11 Testing
interactions involving genome-wide significant loci (of marginal
effects) with a threshold corrected for the actual number of tests has
been suggested10,17,18 and applied successfully in recent studies.16,19–21
Another approach is to select SNPs based on existing biological
knowledge (eg, protein–protein interactions) and test interactions
among them only.22,23 However, cautions should be taken when
making the SNP selection12 because biological knowledge may
not be directly related to the trait studied and any biases in the
pre-identified loci could lead to false-positive epistatic signals.
Here we demonstrate a different approach to exploit the value of
genome-wide analysis of epistasis using multiple populations. First we
performed full pair-wise genome scans for epistasis in BMI in four
GWA populations to which we had direct access: the Scottish
ORCADES,24 the CROATIA-Vis25 and CROATIA-Korcula,26 and the
Italian MICROS27 study cohorts. Each of these cohorts has a relatively
small sample size and is sampled from distinct European regions with
widely differing lifestyles and diets. Second, we identified common
and potentially important gene–gene interactions using the epistasis
signals uncovered in each cohort and their gene ontology (GO)
enrichment across populations. In addition, we also identified a set
of interactions involving the BMI loci (as prior knowledge) in different
cohorts. Third, we tested the identified interactions in each cohort for
replication and then the replicated signals in the Northern Finland
Birth Cohort 1966 (NFBC1966).28 We aim to address the question
whether epistasis analysis is of value for the dissection of the genetic
regulation of BMI in these study cohorts.
MATERIALS AND METHODS
Study cohorts and ethics statement
The four study cohorts have been described in detail elsewhere.24–27,29 Briefly,
the Scottish ORCADES cohort was recruited from a subgroup of 10 islands of
the archipelago of Orkney. This study was approved by the NHS Orkney
Research Ethics Committee and the North of Scotland REC. The CROATIA-Vis
and CROATIA-Korcula cohorts were recruited from the island of Vis and the
island of Korcula, respectively. Both studies were approved by the Ethical
Committee of the Medical School, University of Zagreb and the Multi-Centre
Research Ethics Committee for Scotland. The Italian MICROS cohort was
recruited from villages in an isolated highland area of the South Tyrol. The
study was approved by the ethical committee of the Autonomous Province of
Bolzano. All participants gave written informed consent and were measured for
a number of traits, including weight and height from which BMI values were
calculated.
DNA samples were genotyped with Illumina Infinium HumanHap300v1/v2
(for CROATIA-Vis by the Wellcome Trust Clinical Facility in Einburgh, UK) or
HumanCNV370v1 SNP bead microarrays (for CROATIA-Korcula, ORCADES
and MICROS by the Helmholtz Zentrum Munchen in Munich, Germany) and
analysed using the BeadStudio software (Illumina). Quality control of the
genotype data was performed for each cohort using the R/GenABEL package
(Version 1.6-7)30 based on a common set of criteria: individual call rate at 97%,
SNP call rate at 95%, P-value for deviation from Hardy–Weinberg equilibrium
at 1.0e-10, minor allele frequency at 2%. The NFBC1966 data were provided by
the database of Genotype and Phenotype (dbGaP) via specific Data Use
Certification and used as the replication cohort. NFBC1966 includes nearly
all individuals born in 1966 in the two northernmost Finnish provinces that
were genotyped with HumanCNV370v1 SNP bead microarrays28 and was put
through the same quality control procedure as above. The summary informa-
tion of each cohort after quality control and excluding individuals without BMI
or age records or with extremely high BMI (ie, BMI450 kg/m2) is given in
Table 1.
Statistical analysis
The raw BMI data in each of the four study cohorts were corrected for age and
sex and normalised using the rntransform function that is implemented in the
GenABEL package performing quantile normalisation of residuals from a
generalised linear model analysis. The normalised BMI residuals were then
analysed using a linear mixed model to correct for polygenic effects due to
relatedness using the polygenic function in the GenABEL package and the
resultant environmental residuals (ie, pgresidualY in GenABEL) were used as
the trait to test for association.31 The polygenic heritability was estimated
at the mixed-model step. Following the original GWA study,28 in the
NFBC1966 cohort individuals with pregnancy and/or self reported BMI
measures were excluded, and the raw BMI values were corrected for the
SexOCPG factor (recoded according to gender, status of taking oral contra-
ception and pregnancy) and then normalised and corrected for relatedness
as above.
A single-SNP based GWA scan was performed in each population using a
score test method (based on the additive model) implemented in the mmscore
function in the GenABEL package. The consensus GWA threshold of
7.3 (log10(5.0E08)) was applied to identify GWA significant SNPs.32 We
also performed a full pair-wise genome scan using the regression models
described below. Considering a pair of SNPs denoted as SNP1 and SNP2, the
following genetic models were used to detect epistasis where genotypes of each
SNP (ie, homozygote of the minor allele, homozygote of the major allele and
heterozygote) were fitted as fixed factors:
Model 1 : y ¼ m+SNP1+SNP2+SNP1  SNP2+e ðtwo SNPswith interactionÞ
Model 2 : y ¼ m+SNP1+SNP2+e ðtwo SNPswithout interactionÞ
Model 3 : y¼m+e ðNULLmodelÞ
where y is the trait of interest, m is the model constant, SNP1 (or SNP2) is a
fixed factor with three levels (genotype classes), SNP1*SNP2 is the interaction
term, e is the random error term. The F ratio test of Model 1 against Model 3
evaluates the whole pair effect, including interaction (ie, Fpair, 8 degrees of
Table 1 Summary information of uncorrected BMI (kg/m2)a
Vis Korcula ORCADES MICROS NFBC1966
N 901 880 695 1177 5071
Male/female ratio 0.74 0.56 0.87 0.78 1.0
Age range (years) 18–91 18–98 18–92 18–88 31
Number of SNPs 300265 307712 309202 293913 323697
BMI median 27.10 27.70 27.08 24.89 24.00
BMI mean±SD 27.30±4.19 27.93±4.05 27.76±4.86 25.51±4.57 24.70±4.24
BMI heritability 0.356 0.399 0.514 0.450 0. 216
GWA lambda 1.001 0.999 0.997 0.996 1.005
aVis and Korcula represent CROATIA-Vis and CROATIA-Korcula, respectively.
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freedom). The F ratio test of Model 1 against Model 2 evaluates the interaction
between the two SNPs (ie, Fint, 4 degrees of freedom). P-values were calculated
based on the F distribution with relevant degrees of freedom and transformed
to the log10 scale (ie,log10Ppair for the Fpair test,log10Pint for the Fint test).
We were concerned mainly about the Fint tests in this study.
Genome-wide significant thresholds (all in the log10 scale) were derived
based on Bonferroni correction for multiple tests, that is, the 5% nominal P
value corrected by the number of tests performed. Considering 300 000 SNPs,
a full pair-wise genome scan perform 4.5E+10 association tests and thus the
5% genome-wide threshold is 11.95 (ie, log10(0.05/4.5E+10)). After each
pair-wise genome scan, results were evaluated using the predefined threshold to
identify genome-wide significant interaction signals. Each SNP in the results
was annotated to the nearest gene within a window of 20 kilobases flanking the
SNP (based on the physical distance to either the start or end of transcription of
a gene; the distance is considered as zero if the SNP is within a gene).
A GO enrichment analysis was conducted for each study cohort using
the running mode of ‘Two unranked lists of genes’ in Gorilla33 based on the
standard Hyper Geometric statistics, where the annotated epistatic genes were
used as the target with the full list of human genes as the background. For
simplicity, we chose to use the same log10P value as the consensus GWA
threshold (ie, log10Pint 47.3) to select SNP pairs of each cohort and used
their gene annotations as the input for the GO enrichment analysis. The GO
terms enriched (Po1.0E03) were compared across study cohorts to identify
firstly common GO terms and then their member genes shared by the cohorts.
The shared epistatic genes were examined further for biological functions via
literature mining and their associated interactions in the retained results of each
cohort to identify potentially important interactions for replication tests. The
BMI loci involved SNP pairs (log10Pint47.3) in each study cohort were also
identified as potentially important interaction signals for replication tests.
Genome-wide significant SNP pairs and those identified as potentially
important interactions were tested for replication across the four study cohorts.
The replicated SNP pairs were further tested for replication in the NFBC1966
cohort. Each replication test was done at both the SNP and region
levels. At the SNP level, each replicated SNP was exactly the same as the
corresponding epistatic SNP and thus the 5% nominal significance threshold
(ie, log10(0.05)¼1.30) was used because only one replication test was needed.
At the region level, interactions between each of 10 adjacent SNPs (ie, five
upstream and five downstream) of the first epistatic SNP and each of those of
the second were tested, to accommodate the situation where multiple SNPs
may tag a same mutant of a gene. Permutation was used to derive significance
thresholds for replication of each epistatic pair at the region level, where
phenotypes were permuted and the highest log10Pint value of 121 (ie, 1111)
interaction tests was recorded in each of 1000 iterations. The replicated SNP
pairs were fitted together into the full model to calculate the proportion of
phenotypic variance explained in each study cohort.
RESULTS
The mean BMI was similar across the CROATIA-Vis, CROATIA-
Korcula and ORCADES cohorts but lower in MICROS (Table 1). The
polygenic heritability estimates varied from 0.356 (CROATIA-Vis) to
0.514 (ORCADES). Conventional GWA scans found no genome-wide
significant SNPs in any single cohort. The inflation factor lambda
(computed by regression of observed association P-values against the
expected) of each GWA scan was very close to 1 (Table 1), suggesting
the family relatedness in each cohort was well accounted for. Only
8 out of the 32 BMI SNPs previously identified3 were genotyped in the
four study cohorts and none of these showed a strong association with
BMI (Supplementary Table S1).
Full pair-wise genome scans found no SNP pairs that passed the
genome-wide threshold (log10Pint¼11.95) in any of the four study
cohorts (Figure 1). Considering interaction signals with log10Pint
47.3, MICROS had the least number of SNP pairs and consequently
the least number of annotated genes, whereas the remaining three
cohorts had relatively similar numbers of SNP pairs and annotated
genes (Table 2). Five out of the 32 BMI loci (but not the BMI SNPs)
were involved in 7 epistatic pairs in CROATIA-Vis: FTO, KCTD15,
Figure 1 Pair-wise epistatic signals in each study cohort. (a) Pairwise epistatic signals in CROATIA-Vis. (b) Pairwise epistatic signals in CROATIA-Korcula.
(c) Pairwise epistatic signals in ORCADES. (d) Pairwise epistatic signals in MICROS.
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LRP1B, NEGR1 and PRKD1. Similarly, three BMI loci (NEGR1,
NRXN3 and PRKD1) were involved in CROATIA-Korcula, two
(FTO and MTCH2) in ORCADES and two (FTO and LRP1B) in
MICROS.
GO terms enriched by epistatic genes (log10Pint 47.3) in each
cohort were compared (Supplementary Table S2) and identified 9
common in all four cohorts (Table 3) that might indicate common
regulation mechanisms (eg, GO:0008038 – neuron recognition).
Among the epistatic genes that enriched the 9 GO terms, we found
19 epistatic genes shared by the four cohorts of which 15 are
previously published GWA loci (mostly not genome-wide significant)
associating with various phenotypes34 (Supplementary Table S3).
Most of the 19 shared epistatic genes interacted with one another
despite their interactions being relatively weak (log10Pinto7.3,
Supplementary Table S4) in general, including CDH13 (cadherin 13)
associated with height35 and SORCS2 (sortilin-related VPS10 domain
containing receptor 2) associated with circulating insulin-like growth
factor 1 and insulin-like growth factor-binding protein-3, which are
important for anthropometric traits and risk of cancer and cardio-
vascular disease.36
We further tested replication of the SNP pairs involving either BMI
loci (19, Table 2) or two shared epistatic genes across the study cohorts
(50, Supplementary Table S4). Despite none of the 69 SNP pairs
being genome-wide significant, eight of them had a replication in
one or more cohorts at the SNP level (ie, log10Pint41.30; Table 4).
The best replicated pairs at the SNP level were rs2202167 (NRXN3)
rs11150880 (log10Pint was 8.19, 1.68 and 1.43 in CROATIA-Korcula,
CROATIA-Vis and ORCADES, respectively) and rs1474056 (MTCH2)
- rs7250947 (PLIN4) (log10Pint was 8.08 in ORCADES and 2.44 in
CROATIA-Korcula). The rs11150880 SNP is near the RPH3AL gene,
which is known to have a key role in insulin secretion by pancreatic
cells.37 The PLIN4 gene may be important for intracellular and neutral
lipid storage droplets.38 The eight replicated SNP pairs together
explained the phenotypic variance of BMI by 4, 4, 2 and 0.5% in
CROATIA-Vis, CROATIA-Korcula, ORCADES and MICROS, respec-
tively. By testing replication at the region level, we found the pair of
rs9858278 (NAALADL2) - rs7198915 (CDH13) replicated in CROA-
TIA-Vis, CROATIA-Korcula and MICROS (exceed the 5% thresholds,
Table 4 and Supplementary Table S5). Further testing the nine
replicated SNP pairs in the NFBC1966 cohort found none replicated
at either the SNP or region levels. However, seven out of the nine
pairs had log10Pint42, of which three exceed the 20% thresholds
(Table 4 and Supplementary Table S5).
DISCUSSION
Gene–gene interactions have been suggested as sources of the hidden
genetic variations in GWA studies,6,7 but the extent of their role in this
regard has yet to be demonstrated. One big challenge is that the
sample sizes of many GWA data sets are relatively small (eg, less than
4000 individuals) and hence the power to detect epistasis could be
low.8,13 Therefore studying epistasis in a single GWA population is
unlikely to be fruitful. This is certainly true in our case where
exhaustive genome scans in the four study cohorts found no
genome-wide significant epistasis associated with BMI. We suggest
to tackle the challenge by looking for common (thus potentially
important) gene–gene interactions from sub genome-wide signifi-
Table 4 Replicated interactions involving either the BMI loci or two shared epistatic genes across cohortsa
SNP1 Chr1 Gene1 SNP2 Chr2 Gene2 Vis Korcula ORCADES MICROS NFBC1966
rs953104 1 ATP1A4 rs8008553 14 PRKD1b 8.46c (5.53d) 0.27 (2.84) 0.19 (1.59) 1.34c (2.13) 0.12 (2.11)
rs10256700 7 CNTNAP2 rs10833498 11 NELL1 0.03 (1.94) 6.05c (5.04d) 0.02 (1.66) 1.35c (2.27) 0.42 (2.68f)
rs587791 9 PTPRD rs1408219 13 GPC6 5.05c (3.71d) 0.45 (1.43) 0.06 (2.31) 1.41c (2.60) 0.38 (2.05)
rs3847291 9 PTPRD rs1554941 21 DSCAM 2.21c (2.91e) 0.59 (2.07) 5.03c (3.01e) 0.38 (1.46) 0.77 (2.03)
rs1474056 11 MTCH2b rs7250947 19 PLIN4 0.19 (1.56) 2.44c (1.62) 8.07c (7.84d) 0.36 (2.60) 0.25 (1.24)
rs3783297 14 PRKD1b rs7146371 14 () 0.85 (1.86) 7.52c (6.77d) 0.48 (2.13) 1.67c (1.76) 0.07 (2.90f)
rs2202167 14 NRXN3b rs11150880 17 () 1.68c (2.51) 8.19c (5.98d) 1.43c (2.96) 0.29 (1.54) 0.10 (2.25)
rs11071868 15 MEGF11 rs2665272 16 FTOb 7.97c (3.81d) 1.38c (2.30) 0.31 (1.73) 0.03 (2.39) 0.09 (2.80f)
rs9858278 3 NAALADL2 rs7198915 16 CDH13 4.24c (3.48d) 0.01 (3.17d) 0.43 (2.08) 0.93 (3.16d) 0.02 (1.20)
aSNP1 (SNP2): the first (second) SNP name; chr1 (chr2): the chromosome where SNP1 (SNP2) locates; gene1 (gene2): symbol of the gene annotated by SNP1 (SNP2); log10Pint value at the SNP
(region) level; Vis: CROATIA-Vis; Korcula: CROATIA-Korcula; (–): no gene annotated; 5%, 10% and 20% thresholds derived for replication at the region level in Supplementary Table S5.
bOne of the BMI loci.
clog10Pint41.30 at the SNP level.
dSignificant at the 5% threshold.
eSignificant at the 10% threshold.
fSignificant at the 20% threshold.
Table 2 Number of SNP pairs and genes annotated at
log10Pint47.3 in each study cohorta
Cohort
SNP
pair
Gene
annotated
SNP pair with
BMI loci
BMI
loci
Vis 1365 1011 7 5
Korcula 1237 971 5 3
ORCADES 1335 890 4 2
MICROS 785 639 3 2
aVis and Korcula represent CROATIA-Vis and CROATIA-Korcula, respectively.
Table 3 Common GO terms enriched by epistatic genes in CROATIA-
Vis (Vis), CROATIA-Korcula (Korcula), ORCADES and MICROSa
GO term Description Vis Korcula ORCADES MICROS
GO:0008038 Neuron recognition 2.07E06 1.78E05 8.38E07 1.13E04
GO:0022610 Biological adhesion 2.49E06 3.16E05 3.72E05 3.59E05
GO:0007155 Cell adhesion 2.49E06 3.16E05 3.72E05 3.59E05
GO:0044459 Plasma membrane part 1.51E09 5.88E08 6.06E13 1.54E05
GO:0042995 Cell projection 1.16E07 6.42E06 1.63E07 1.81E07
GO:0043005 Neuron projection 1.23E05 7.05E06 2.56E06 1.59E07
GO:0044425 Membrane part 2.82E05 1.43E05 2.00E11 3.25E06
GO:0044456 Synapse part 4.15E05 6.97E04 7.50E05 4.07E04
GO:0005886 Plasma membrane 6.02E04 1.85E06 4.29E07 6.28E06
aThe process, function and component GO terms are in the first, second and third panels,
respectively.
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cant epistatic signals (log10Pint47.3) in multiple GWA populations.
We showed that GO enrichment analysis could be used to identify
common GO terms (ie gene function groups) enriched by the epistatic
signals in the four study cohorts from which 19 shared epistatic genes
were identified. Most of the 19 shared epistatic genes are previously
identified GWA loci associating with phenotypes other than BMI and
interacted with one another. Their interactions were considered
potentially important because they belong to one or multiple com-
monly enriched GO terms. Interactions involving at least one of the
32 BMI loci with log10Pint47.3 were also considered potentially
important assuming the BMI loci are likely interactive.
Being aware of possible noises in those potentially important
interactions, we used replication to identify the most reliable epistatic
signals across the study cohorts. Eight epistatic pairs involving either
the BMI loci or two shared epistatic genes showed replication at the
SNP level in at least one cohort (Table 4). The eight epistatic pairs
together could indeed explain a considerable proportion of the BMI
variation in each individual cohort. Nevertheless, caution is recom-
mended in light of the potential overestimation of the effects due to
the ‘winner’s curse’.39 Besides, none of the eight epistatic pairs were
replicated in all of the four study cohorts, or in the replication cohort
NFBC1966. Further replication tests in other populations and/or
functional assays are useful to confirm whether they are true signals.
Statistical replication has been used as the golden rule to prevent
reporting false positives in GWA studies. This however appears to be
far more difficult for epistatic signals than for single SNP signals for
reasons, including power, minor allele frequency change, and linkage
disequilibrium between epistatic SNP and mutant for both loci.16 The
moderate log10Pint values of the epistatic pairs tested for replication
suggest that the linkage disequilibrium between epistatic SNPs and
mutants is not high so replication of these pairs will be difficult.
Furthermore, different environments may cause different phenotype
distributions in the discovery and replication cohorts. The lack of
replication in the NFBC1966 cohort could be due to two important
environmental factors of BMI: age40 (ie, 31 vs a range between 18 and
90 in the study cohorts) and diets.29
The approach based on common gene–gene interactions in multi-
ple GWA populations is an effective solution to the issue of limited
power of detection of epistasis. It is just a partial solution though
because some ignored interactions may be important as well. Com-
parison of sub genome-wide significant epistatic signals across multi-
ple populations can be made at either the SNP, or gene or pathway
level and seem more fruitful at the gene or pathway level than the SNP
level. The approach may become more useful if better annotation
methods (considering only GWA signals without interactions)41 can
be adapted to epistasis. For example, not all epistatic SNPs
were annotated to genes in the study and hence did not contribute
to the enrichment analysis. The approach will likely remain important
even once new tools for meta-analysis of epistasis in GWA data sets
become available to increase power for detection of epistasis.
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